In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

A groundbreaking clinical trial has revealed that weight-loss injections marketed as Ozempic and Wegovy may significantly ...

Ozempic, known for aiding weight loss, could also help in treating alcohol addiction, as a study in JAMA Psychiatry suggests.

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

In addition, the mean body weight was reduced by 17, 21 and 25 pounds, respectively, as compared to 13 pounds with Ozempic 1 mg. The next battle? Simply stating Mounjaro is better than Ozempic is ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.